Trial Profile
Open-label, single centre, phase I pharmacokinetic study of DSC 127 in diabetic patients with chronic non-healing foot ulcers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2013
Price :
$35
*
At a glance
- Drugs Aclerastide (Primary)
- Indications Diabetic foot ulcer
- Focus Pharmacokinetics
- 26 Jun 2013 New trial record